Product Code: ETC332181 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Measles, Mumps And Rubella Vaccines Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 China Measles, Mumps And Rubella Vaccines Market - Industry Life Cycle |
3.4 China Measles, Mumps And Rubella Vaccines Market - Porter's Five Forces |
3.5 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 China Measles, Mumps And Rubella Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and importance of vaccination programs in China |
4.2.2 Government initiatives to improve vaccination coverage and control outbreaks |
4.2.3 Rising incidences of measles, mumps, and rubella in China |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy and misinformation among the population |
4.3.2 Stringent regulations and approval processes for vaccines in China |
4.3.3 Competition from other preventive healthcare measures |
5 China Measles, Mumps And Rubella Vaccines Market Trends |
6 China Measles, Mumps And Rubella Vaccines Market, By Types |
6.1 China Measles, Mumps And Rubella Vaccines Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Monovalent, 2021 - 2031F |
6.1.4 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Combinational, 2021 - 2031F |
6.1.5 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Divalent, 2021 - 2031F |
6.1.6 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Trivalent, 2021 - 2031F |
6.1.7 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 China Measles, Mumps And Rubella Vaccines Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.2.3 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Healthcare Centers, 2021 - 2031F |
6.2.4 China Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 China Measles, Mumps And Rubella Vaccines Market Import-Export Trade Statistics |
7.1 China Measles, Mumps And Rubella Vaccines Market Export to Major Countries |
7.2 China Measles, Mumps And Rubella Vaccines Market Imports from Major Countries |
8 China Measles, Mumps And Rubella Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rates for measles, mumps, and rubella in China |
8.2 Number of reported cases of measles, mumps, and rubella in China |
8.3 Public perception and acceptance of measles, mumps, and rubella vaccines |
8.4 Investments in research and development for innovative vaccine technologies |
8.5 Adherence to vaccination schedules and guidelines in China |
9 China Measles, Mumps And Rubella Vaccines Market - Opportunity Assessment |
9.1 China Measles, Mumps And Rubella Vaccines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Measles, Mumps And Rubella Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 China Measles, Mumps And Rubella Vaccines Market - Competitive Landscape |
10.1 China Measles, Mumps And Rubella Vaccines Market Revenue Share, By Companies, 2024 |
10.2 China Measles, Mumps And Rubella Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |